Roundtable Discussion: Defining Quality Control Strategies That Support Speed, Compliance & Global Trial Execution for Personalized Vaccines

• Defining scalable QC frameworks for PCVs by identifying which release assays reduce redundancy, batch release time, and regulatory rework at Phase II and beyond

• Applying risk-based release strategies in bespoke manufacturing workflows to enable faster, compliant release of low-volume batches

• Designing digital QA systems early on to support faster QP release as batch volumes increase